American Portfolios Advisors’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
RFWA
SMG
FAIM
AWCI
American Portfolios Advisors's BBP Position: Q2 2019 in Review
American Portfolios Advisors sold out of Virtus Biotech ETF (BBP) in Q2 2019, closing a stake of 1,155 shares — an estimated $51.8K sold.
American Portfolios Advisors first reported a position in BBP in Q1 2019 and held it in 1 quarter. The position peaked at $51.8K in Q1 2019. 21 funds tracked by Wall St. Rank hold BBP as of Q2 2019.
- American Portfolios Advisors reported no remaining Virtus Biotech ETF position as of Q2 2019 after selling out during the quarter.
- American Portfolios Advisors sold 1,155 Virtus Biotech ETF shares in Q2 2019, an estimated $51.8K.
- American Portfolios Advisors first reported a position in Virtus Biotech ETF in Q1 2019 and held it in 1 quarter.
- American Portfolios Advisors's Virtus Biotech ETF position peaked at $51.8K in Q1 2019.
- 21 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2019.
Based on American Portfolios Advisors's 13F filing for Q2 2019, filed 24 Mar 2023.